(NewsNation) — Eli Lilly says it now plans to seek FDA approval in early 2027 for its next-generatio...
Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide
(NewsNation) — Eli Lilly says it now plans to seek FDA approval in early 2027 for its next-generation weight-loss drug, retatrutide, following positive...
Author: NewsNation
Read Original Article